AwardedBelgiumGoodsFramework agreement
Aankoop van heparines met een laag moleculair gewicht
- Published
- Published 12 December 2025
- Deadline
- Closed 29 January 2026
Overview
Jessa Ziekenhuis procured low-molecular-weight heparin (LMWH) through a framework agreement divided into two lots: acute coronary syndrome indications (STEMI and NSTEMI) and other indications, with a maximum estimated value of €1.184 million over four years. Leo Pharma was awarded the contract on 5 May 2026 for €292,455.84.
Key details
- Country
- Belgium
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 12 December 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €292,456
- Award date
- 5 May 2026
- Contract period
- 6 May 2026 → 5 May 2030
- Leo Pharma
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 June 2026
Contract Notice
19 December 2025
Contract Notice
12 December 2025
Contracting authority
vzw Jessa Ziekenhuis
Procuring entityHasselt, Belgium
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.